Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol
To evaluate the implementation of 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) surveillance after (chemo)radiotherapy, to compare outcomes for those who achieved a complete (CR), equivocal (EQR) and incomplete (ICR) nodal response on 12-week PET-CT according to their human papillomavirus (HPV) status, and to assess the safety of ongoing surveillance beyond 12 weeks in the HPV-positive EQR group.
Source: Clinical Oncology - Category: Radiology Authors: S. Zhou, R. Rulach, F. Hendry, D. Stobo, A. James, M.-F. Dempsey, D. Grose, C. Lamb, S. Schipani, M. Rizwanullah, C. Wilson, Y.C. Lau, C. Paterson Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Genital Warts | Head and Neck Cancer | Human Papillomavirus (HPV) | PET Scan | Radiology | Squamous Cell Carcinoma